Sitagliptin induced Stevens Johnson Syndrome in an Elderly Diabetic Patient

Megha Garg, Girish Joseph, Neena Bhatti, Riya Y Mittal

Abstract: Sitagliptin is being used as a monotherapy or combination therapy for management of type 2 diabetes mellitus. Very few cutaneous adverse events have been reported with the suspect drug and rarer is the occurrence of Steven Johnsons syndrome.

Keywords: Sitagliptin, Stevens Johnson Syndrome, Diabetic patient